World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 17 October 2012
Main ID:  NCT00515840
Date of registration: 13/08/2007
Primary sponsor: University of Aberdeen
Public title: GPIAG and Leicester Asthma and Dysfunctional Breathing (GLAD) Study: a Randomised Controlled Study GLAD
Scientific title: GPIAG and Leicester Asthma and Dysfunctional Breathing (GLAD) Study: a Randomised Controlled Study
Date of first enrolment: October 2003
Target sample size: 182
Recruitment status: Active, not recruiting
URL:  http://clinicaltrials.gov/show/NCT00515840
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment  
Countries of recruitment
Contacts
Name:   Mike Thomas
Address: 
Telephone:
Email:
Affiliation:  University of Aberdeen
Key inclusion & exclusion criteria

Inclusion Criteria:

- Asthma diagnosis in medical records

- Age 17-70 yrs.

- One or more prescription for asthma medication in previous 12 months

- Impaired asthma related quality of life (AQLQ score <5.5)

Exclusion Criteria:

- COPD

- Unstable or under-treated asthma at enrollment.



Age minimum: 17 Years
Age maximum: 70 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Asthma
Dysfunctional Breathing
Intervention(s)
Other: Physiotherapist
Primary Outcome(s)
Change in AQLQ scores between intervention and control groups in subjects with positive NQ screening scores 1 month post intervention Change in AQLQ scores between intervention groups of subjects with positive and negative NQ screening scores [Time Frame: Dec 2006]
Secondary Outcome(s)
Changes in bronchial hyperresponsiveness(PC 20), sputum eosinophil counts and exhaled NO between intervention and control groups in subjects with positive and negative NQ screening scores Change in ACQ Score between the intervention and the control gr [Time Frame: Dec 2007]
Secondary ID(s)
03/014
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
University Hospitals, Leicester
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history